GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,562,000 | +16.1% | 36,500 | +46.0% | 0.26% | +17.9% |
| Q2 2020 | $3,069,000 | -37.6% | 25,000 | -55.4% | 0.22% | -50.2% |
| Q1 2020 | $4,917,000 | +8.1% | 56,000 | +28.7% | 0.45% | +78.6% |
| Q4 2019 | $4,547,000 | -70.7% | 43,500 | -67.8% | 0.25% | -76.9% |
| Q3 2019 | $15,518,000 | +43.9% | 135,000 | +116.0% | 1.09% | +44.6% |
| Q2 2019 | $10,785,000 | +19.5% | 62,500 | +16.8% | 0.75% | +19.5% |
| Q1 2019 | $9,023,000 | +73.4% | 53,500 | 0.0% | 0.63% | +39.7% |
| Q4 2018 | $5,204,000 | – | 53,500 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |